<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Inst for Cell and Molecular Biosciences</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F75953F9-3B1B-4B69-846E-89545B0EC8C0"><gtr:id>F75953F9-3B1B-4B69-846E-89545B0EC8C0</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>Hugh</gtr:otherNames><gtr:surname>Lakey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B0FBFB48-8413-4109-B289-AAEB2728D41A"><gtr:id>B0FBFB48-8413-4109-B289-AAEB2728D41A</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>German</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E5421327-94FD-491C-A2F1-7A24526F6C52"><gtr:id>E5421327-94FD-491C-A2F1-7A24526F6C52</gtr:id><gtr:firstName>Nick J.</gtr:firstName><gtr:surname>Reynolds</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F7DE9260-0B43-4D58-8F0E-FA396A73934A"><gtr:id>F7DE9260-0B43-4D58-8F0E-FA396A73934A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Fulton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3CCBA1A8-712E-4D6A-B4C3-B275B8E6E9EB"><gtr:id>3CCBA1A8-712E-4D6A-B4C3-B275B8E6E9EB</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Donald</gtr:otherNames><gtr:surname>Perkins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FM018318%2F1"><gtr:id>B2057AF2-15D1-4001-85AE-15D720A72FAD</gtr:id><gtr:title>Manufacture of complex protein polymers for industry and medicine</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M018318/1</gtr:grantReference><gtr:abstractText>Modern biomedical science and clinical medicine rely increasingly upon the growth of cells outside of the body. In this way we can perform animal free experiments which are highly informative about a range of diseases including cancer, arthritis and dementia. We can also use these artificial cell cultures to make new drugs and there is a growing industry making such drugs as Herceptin for cancer and vaccines against hepatitis. Finally we now have the hope of stem cells to create a range of regenerative medicine cures for a range of conditions. In all these cases the cells are growing outside of the body and often require an external scaffolding of molecules to support their normal growth patterns. Currently these scaffolds are every expensive and of limited technical complexity. This project will create a cheap, pure and highly flexible source of polymeric proteins which can be built into a range of products to accelerate and stabilise the growth of cells in culture and assist all the technologies mentioned above.</gtr:abstractText><gtr:technicalSummary>Artificial cell culture is a widespread and rapidly expanding technology with applications in medicine, bioprocessing, crop science, drug development and clinical research. Currently, cells grow on surfaces that largely fall into two groups; low cost, bulk materials, exemplified by plastic ware, or high cost, low volume molecules such as proteins or peptide hydrogels. This project seeks to use a recent and patented discovery to create a novel industrial process that will overturn this product landscape by manufacturing engineered protein polymers with advanced functions at low cost. By bridging the gap between traditional polymer science and protein biochemistry we will create a range of matrices to assist the growth of cells for many downstream applications. The five-year project, supported by a broad industrial advisory board will develop a series of prototype materials and production processes and create the foundation for informed private sector investment or public-private partnerships.</gtr:technicalSummary><gtr:potentialImpactText>As described in proposal submitted to TSB</gtr:potentialImpactText><gtr:fund><gtr:end>2020-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2015-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1880175</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visit Ponteland</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4A6C1703-FED1-4825-BF2D-14339D2F25EE</gtr:id><gtr:impact>We first visit the school and then later host the children in a practical lab in our institute . The result is a lot of excited kids talking about science and asking loads of questions

School reports a more informed approach to science lessons after they have spent a day doing research</gtr:impact><gtr:outcomeId>545e555865cc71.80490478</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006,2006,2008,2009,</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We are progressing through the US examination stage.</gtr:description><gtr:grantRef>BB/M018318/1</gtr:grantRef><gtr:id>6CE56725-205E-489E-894A-F341E5AFF30E</gtr:id><gtr:impact>granting of the patent in the USA is critical to the broad development of the Caf1 polymer material</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b928409fb160.78246349</gtr:outcomeId><gtr:patentId>US 14/407,424;</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Recombinant Polypeptide</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2E345E55-344C-4DD5-A9BD-0FAC8944AA19</gtr:id><gtr:title>Thermal stability and rheological properties of the 'non-stick' Caf1 biomaterial.</gtr:title><gtr:parentPublicationTitle>Biomedical materials (Bristol, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5faf22d28e176b66f394d6a984cfa469"><gtr:id>5faf22d28e176b66f394d6a984cfa469</gtr:id><gtr:otherNames>Ulusu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1748-6041</gtr:issn><gtr:outcomeId>5aa6955bb43e88.04642048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A40EDB6-8A33-40D1-A9D6-887917EF0617</gtr:id><gtr:title>Caf1 of Yersinia pestis Forms Complex Highly Stable Protein Polymers and Hydrogel Scaffolds</gtr:title><gtr:parentPublicationTitle>BIOPHYSICAL JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e507739b9f9715bde1634c3863a8e2f4"><gtr:id>e507739b9f9715bde1634c3863a8e2f4</gtr:id><gtr:otherNames>Waller Helen</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>58b92a52ca6343.19687512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBA69C5C-93CA-4849-97E7-8C7E19FBB38E</gtr:id><gtr:title>Insight into Interface Engineering at TiO
 
 /Dye through Molecularly Functionalized Caf1 Biopolymer</gtr:title><gtr:parentPublicationTitle>ACS Sustainable Chemistry &amp; Engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d96d504ab21bd9cbec0fa4838a96190a"><gtr:id>d96d504ab21bd9cbec0fa4838a96190a</gtr:id><gtr:otherNames>Akin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa69498de9a07.74820061</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/M018318/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>E847DD9B-2053-4BC7-97A9-4213B185C968</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Materials sciences</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>18D298A9-FFE3-432F-B077-E3B703272E29</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemical engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>BD108981-2A72-4C45-AAC2-425461EB90BE</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomaterials</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>7F6E0C83-7643-4C72-95C4-2160B6B43F14</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bionanoscience</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>73EF98E1-3FA8-46A0-BE46-00AE16C7D999</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Communication &amp; signalling</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>